Earlier Initiation of TamifluĀ® Treatment Improves Clinical Benefits for Children with Influenza
New data show benefits of early treatment with Tamiflu in reducing influenza Illness duration, symptom severity & secondary complications --Treatment initiated within 24 hours of symptom onset provides clinically meaningful improvements, compared with treatment initiated within 24 - 48 hours -- Tamiflu, the leading prescription antiviral flu medication, is indicated for the prevention and treatment of influenza types A and B in patients one year and older.
Influenza: Easy Steps to Tackle Flu or Grippe
IDENTIFYING INFLUENZA
NWHRC Launches New Online Tool Kit to Help Parents Fight Influenza this Season Tool Kit Highlights Three Simple Flu-Fighting Steps: Vaccination, Anti
With cold and flu season already affecting many areas of the United States, the not-for-profit National Women's Health Resource Center (http://www.healthywomen.org) (NWHRC) announced the launch of its Flu-Fighting Tool Kit for Parents, which provides comprehensive information and tips on how to curb the spread of flu. The tool kit (http://www.healthywomen.org/flufighting/) highlights three flu prevention and treatment steps: Vaccination ("flu shot"), antiviral medication, good hygiene.
Symptoms of Influenza Flu
Influenza flu is very common during the time of seasonal flu and brings a situation whereby one suffers from fever, chills, muscle pain, body aches, fatigue or headache. Some of the symptoms that remain unnoticed during the initial period may include dry cough, running nose and sore throat.
Influenza Antibody Spray Success: Opens New Approach to Respiratory Disease Control
Anadis Limited (ASX: ANX), a research driven biopharmaceutical company focused on polyclonal antibodies to address human disease, announced today important progress concerning its accelerated program to develop a nasal antibody spray to provide immediate post-exposure prophylaxis against a range of influenza viruses.
Tamiflu for Flu Prevention and Treatment
Tamiflu flu medicine is the first choice of doctors. It is approved for prevention and treatment of influenza in adults as well as in children aged 1 year and older.
Roche Announces TamifluĀ® Antiviral Flu Medication in Ample Supply for 2008-2009 Flu Season
Roche announced today that ample supplies of its prescription antiviral medication TamifluĀ® (oseltamivir phosphate) will be widely available throughout the U.S. this flu season. Tamiflu, cited by the Centers for Disease Control and Prevention (CDC) as an important second line of defense against flu, is indicated for the treatment and prevention of influenza in adults and children one year and older.
What to do About the Flu - Dr's Top 10 Tips For Flu Prevention
With the flu season fast approaching it's important that you do what you can to avoid it - especially if you are within an at risk category based on your age or general health One thing alone will not be enough - for example you can't expect a flu shot by itself to keep you immune
Avian Influenza - Bird Flu FAQ
As more and more cases of bird flu are reported, the world faces an immediate threat of a deadly pandemic. Pandemics (Global Disease Outbreaks) are known to be like flash floods. They start abruptly, spread fast and cause a lot of damage all over the world.
Bird Flu and Flu Pandemic -- How to Reduce the Risk of Infections
Infection prevention more important than ever, says world experts -- but research shows many fall short in practicing good hygiene in daily lives. NO-GERMS™ Portable Hand Sanitizer has been proven effective against bird flu (Avian Flu H5N1 Virus) on the hands, in independent tests at Retroscreen Virology, Queen Mary's School of Medicine and Dentistry, University of London.
Influenza- causes, symptoms and treatment
Influenza is commonly known as flu, it is an infectious disease of birds that can cause by RNA viruses. It is a contagious respiratory illness that is caused by influenza virus. Actually it is a viral infection that affects throat, nose, bronchi and in some cases it also affects lungs.
Facts about Influenza Flu Medications
Influenza, also known as flu is an infectious disease that spreads through upper airways and lungs in mammals. Common symptoms of influenza found are fever, sore throat, muscle pains, severe headache, coughing, weakness, and fatigue.
Natural Prevention & Treatment For The Flu: What Your Doctor May Not Know
Flu can affect 10 to 30 percent of the U.S.
Avian Flu Talk: Suspected Bird Flu Patients Continue to Rise
The most recent reports in Indonesia indicate that the number of suspected cases is still increasing, but the Public Health Ministry has been slow to confirm these reports.
H5N1 Virus Replikin Gene Counts Indicate a New More Virulent Influenza Cycle Has Begun
Replikins Ltd. has found that H5N1 virus replikin peak gene counts in 2007 in Hong Kong, Russia, Indonesia, Vietnam and Israel indicate that a new replikin cycle has begun. The mean replikin count exceeded the maximum of the previous cycle identified by the company. Although several conditions are required to produce a pandemic, the increase in replikin count, a feature of each of the last three pandemics, is now in the range of the increase seen in the 1918 H1N1 pandemic.
|
 |
 |
Human H5N1 Virus Replikin Count Overtakes Levels in H5N1 'Bird Flu'
Boston, MA (PRWeb) December 27, 2006 - A common question asked at current scientific conferences is: 'where did bird flu go?'
The recent decrease in reported h5n1 human cases and bird outbreaks might indicate that the virus has become dormant. However, quantitative analysis by Replikins, Ltd. of human h5n1 virus sequences in 2006 has found that the Replikin Count™ has significantly increased beyond all annual previous levels reported in chickens and humans. The Replikin Count determined by virus protein software analysis, provides an index of the capacity for virus rapid replication. The Replikin Count is defined as the number of replikin peptide sequences per 100 amino acids of virus protein, that is concentration, and is independent of the number of specimens examined.
Rather than declining, the Replikin Count in humans in 2006 has risen 35% over that in 2005, and outstripped the Count in all reported chicken n5n1 virus specimens, both with reference to the mean and the range, of the peptides in all human h5n1 virus specimens reported in National Library of Medicine
With the rise in Replikin Count in human h5n1, 3.7 (+-4.1) in 2005 to 5.0 (+-5.9) in 2006, p less than 0.002, the human Count exceeds that for H5N1 in chickens, which after rising from 2003, has been constant, 3.2(+-2.8) in 2005, and 3.2(+-3.1) in 2006. The Replikin Count in h5n1 is now seen to have risen steadily, by a factor of 3.9 from the 1998 Replikin Count of 1.3 (+-0.4) in chickens to the Replikin Count™ in humans in 2006 of 5.0 (+-5.9) (p less than 0.001). The Replikin Count in the 1918 h1n1 influenza pandemic was 7.0. The mortality rate in human h5n1 cases has also increased 2.3 times, from 26 percent in 1997-98 to approximately 60 percent in 2006.
The increase in Replikin Count could have provided early warning of the last three H5N1 bird outbreaks in years 2001-2006. It was also found to precede or was an early association of the three influenza human pandemics - 1918 (h1n1), 1957 (h2n2) and 1968 (h3n2), and the h5n1 outbreak in Hong Kong (1997) - see Replikins website for detailed data.
In contrast to h5n1, Replikin Count™ analyses of h3n2 influenza virus (the cause of the pandemic of 1968) has decreased - 2.7 (+-0.6) in 2005 to 0.8 (+-1) in 2006, p less than 0.001. Such decreases have been associated with periods of relative viral quiescence.
"This rise in human h5n1 Replikin Count suggests that the replication rate of this virus in humans continues to increase. Humans may be becoming a preferred host for H5N1" according to Dr. Sam Bogoch, Chairman of Replikins, Ltd.
"The Replikin Count is specific to the virus strain, the host species, and the region, and can be used to indicate the threat level of a particular virus. We know of no other quantitative measures of particular peptide sequences of virus proteins, or of any other chemical constituent, which have this correlative and predictive value" he said.
In addition to FluForecast®, Replikins, Ltd. has enlisted an international 'Replikins Group' of several universities and research institutions to test the effect of its potential synthetic replikins vaccines and other products against these new targets related to rapid replication in H5N1 and other virus disorders.
###
This press release has been reprinted from PRWEB per the terms and conditions of the copyright notice.
|